ClinicalTrials.Veeva

Menu

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold (CSI-Ulm-BVS)

U

University of Ulm

Status

Completed

Conditions

Ischemic Heart Disease
Coronary Artery Disease
Unstable Angina
Stable Angina
Acute Myocardial Infarction

Treatments

Device: use of bioresorbable vascular scaffolds

Study type

Interventional

Funder types

Other

Identifiers

NCT02162056
CSI-Ulm-BVS 1.0

Details and patient eligibility

About

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Full description

Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.

Enrollment

326 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • coronary artery disease
  • implantation of at least one bioresorbable vascular scaffold

Exclusion criteria

  • no written informed consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

326 participants in 1 patient group

use of bioresorbable vascular scaffolds
Experimental group
Description:
Implantation of bioresorbable vascular scaffold for coronary artery disease.
Treatment:
Device: use of bioresorbable vascular scaffolds

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems